Leo Pharma's new drug for atopic dermatitis receives EU approval

Leo Pharma received a recommendation from the expert panel of the European Medicines Agency in April, and the commission has followed this advice, approving the eczema treatment Adtralza from the Danish company.
Photo: Leo Pharma / PR
Photo: Leo Pharma / PR

Now, Leo Pharma can get properly started on launching the drug Adtralza in the EU.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading